Feasibility of using convalescent plasma immunotherapy for MERS-CoV infection, Saudi Arabia

Authors :: Arabi, Yaseen M.
Hajeer, Ali H.
Luke, Thomas
Raviprakash, Kanakatte
Balkhy, Hanan
Johani, Sameera
Dawood, Abdulaziz Al-
Qahtani, Saad Al-
Omari, Awad Al-
Hameed, Fahad Al-
Hayden, Frederick G.
Fowler, Robert
Bouchama, Abderrezak
Shindo, Nahoko
Khairy, Khalid Al-
Carson, Gail
Taha, Yusri
Sadat, Musharaf
Alahmadi, Mashail
Source :: Emerging Infectious Diseases. September, 2016, Vol. 22 Issue 9, p1554, 8 p.
Publication Year :: 2016
Abstract: Middle East respiratory syndrome coronavirus (MERS-CoV) was initially identified in September 2012 when a patient in Saudi Arabia with a severe, acute respiratory infection and acute renal failure died (1). [...]

Subjects :: Mortality -- Research -- Risk factors -- Saudi Arabia
Middle East respiratory syndrome -- Research -- Care and treatment -- Identification and classification
Immunotherapy -- Health aspects -- Usage
Health

Full Text Access

Tools